American Portfolios Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
American Portfolios Advisors's NVO Position: Q3 2022 in Review
American Portfolios Advisors reduced its Novo Nordisk (NVO) stake by 15% in Q3 2022, selling an estimated $67.4K and leaving 7,216 shares worth $359K. The position accounts for 0.02% of the portfolio, ranked #775.
American Portfolios Advisors first reported a position in NVO in Q4 2017 and has held it in 20 quarters since. The position peaked at $481K in Q4 2021. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.
- American Portfolios Advisors held 7,216 shares of Novo Nordisk worth $359K as of Q3 2022.
- American Portfolios Advisors sold 1,258 Novo Nordisk shares in Q3 2022, an estimated $67.4K.
- Novo Nordisk made up 0.02% of American Portfolios Advisors's portfolio in Q3 2022, its #775 holding.
- American Portfolios Advisors first reported a position in Novo Nordisk in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's Novo Nordisk position peaked at $481K in Q4 2021.
- 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.